Ming-Ann Hsu Selected Research

Negative rheumatoid factor polyarthritis

11/2021

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Ann Hsu Research Topics

Disease

12	Psoriatic Arthritis 01/2021 - 10/2018
6	Fatigue 01/2021 - 01/2019
6	Chronic Disease (Chronic Diseases) 01/2021 - 01/2019
4	Pain (Aches) 01/2021 - 01/2019
3	Necrosis 01/2020 - 01/2019
3	Ankylosing Spondylitis 01/2020 - 01/2019
3	Neoplasms (Cancer) 07/2008 - 11/2005
2	Infections 11/2021 - 01/2020
2	Arthritis (Polyarthritis) 11/2021 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 09/2014 - 09/2014
1	Negative rheumatoid factor polyarthritis 11/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2020
1	Rheumatic Diseases (Rheumatism) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Melanoma (Melanoma, Malignant) 07/2008
1	Lung Neoplasms (Lung Cancer) 07/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2006
1	Mouth Neoplasms (Oral Cancer) 11/2005

Drug/Important Bio-Agent (IBA)

8	tofacitinibIBA 11/2021 - 01/2019
4	Janus Kinase InhibitorsIBA 09/2020 - 10/2018
4	Antirheumatic Agents (DMARD)IBA 01/2020 - 10/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 10/2018
2	Biological ProductsIBA 01/2020 - 07/2008
2	Desvenlafaxine Succinate FDA Link 09/2014 - 09/2014
1	Rheumatoid FactorIBA 11/2021
1	apremilastIBA 01/2020
1	Adalimumab (Humira)FDA Link 01/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 11/2005
3	Drug Therapy (Chemotherapy) 03/2006 - 11/2005